Latest News and Press Releases
Want to stay updated on the latest news?
-
Recipharm and ProductLife Group announce a strategic collaboration aimed at supporting (bio)pharmaceutical companies.
-
San Antonio, Texas, May 06, 2025 (GLOBE NEWSWIRE) -- BBG Advanced Therapies, a subsidiary of San Antonio-based nonprofit BioBridge Global, has unveiled the first vehicle of its kind in the world, a...
-
New York, United States, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The therapeutic use of cells to address medical issues or illnesses is known as cell therapy. Cells or tissues are transplanted into a...
-
Press Release 4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy Company founded by 4BIO Capital and...
-
Press Release 4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy Company founded by 4BIO Capital and...
-
Press Release 4BIO Capital Becomes First UK Venture Fund Certified by Japan's AMED 4BIO Capital named as the first and only UK-based venture fund to be accredited by the Japan Agency for Medical...
-
Press Release 4BIO Capital Becomes First UK Venture Fund Certified by Japan's AMED 4BIO Capital named as the first and only UK-based venture fund to be accredited by the Japan Agency for Medical...
-
Press Release LONDON, 4 November 2024 – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm focused solely on the advanced and emerging therapies sector, announces today the...
-
Press Release LONDON, 4 November 2024 – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm focused solely on the advanced and emerging therapies sector, announces today the...
-
March Bio is rapidly advancing its innovative autologous chimeric antigen receptor T-cell (CAR-T) therapy, MB-105, in development for the treatment of relapsed and refractory CD5 positive T-cell...